KRAS and cancer: RAS, comprising 3 genes, H-RAS, K-RAS and N-RAS, that encode proteins that play critical roles in key cell signaling pathways, and is the second most prevalent gene driver mutation across diverse human cancers, manifesting in 20% to 30% of all human malignancies [45].